IHC – Ashbrook DST Investor Lawsuit Investigation
Have you suffered losses involving IHC-Ashbrook DST? If you invested in IHC – Ashbrook DST or other Inspired Healthcare Capital offerings and are now facing losses, you may be entitled to recovery. The White Law Group is investigating potential FINRA arbitration claims on behalf of investors in light of the firm’s recent decision to suspend investment offerings and distributions amid an alleged U.S. Securities and Exchange Commission (SEC) investigation.
About the Offering – Form D Filing
According to a Form D filed with the SEC, IHC – Ashbrook DST sought to raise approximately $17,726,474 from investors in 2020. The investment was structured as a Delaware Statutory Trust (DST), marketed primarily to 1031 exchange investors seeking passive income and potential tax deferral benefits.
Suspended Distributions and January 2026 Update
Inspired Healthcare Capital–sponsored DST investors reportedly received an important letter in January 2026 confirming suspended distributions, ongoing regulatory review, and restructuring oversight.
In that update, IHC disclosed that:
-
Investor distributions were suspended in 2025 and remain halted
-
No new investor capital will be raised
-
The company has placed its businesses under independent management and restructuring oversight
-
DST properties, including Chesterfield, are managed by third-party operators
-
A Chief Restructuring Officer (CRO) and independent directors have been appointed to oversee operations and financial decisions
These developments confirm that the company continues to navigate significant financial stress and operational uncertainty, with no clear timeline for resuming distributions.
Understanding the Risks of DST Investments
Delaware Statutory Trusts like Chesterfield are private placement, illiquid real estate investments often marketed for 1031 exchange benefits and passive income. However, these offerings carry substantial risk:
-
Illiquidity: No established secondary market exists; investors cannot readily sell beneficial interests
-
High commissions and fees: Upfront selling compensation and fees reduce net invested capital
-
Sponsor control and conflicts: Investors lack control over operations, while affiliates may profit regardless of performance
-
Limited disclosure: Regulation D offerings do not require the same level of ongoing SEC reporting as public securities
-
Operational risk: Performance depends on occupancy, cost control, and third-party management execution
These factors make DSTs unsuitable for many retail investors, especially those seeking stable income or capital preservation.
FINRA Arbitration for Recovery of Investment Losses
The White Law Group is investigating the liability that FINRA-registered brokerage firms may have for improperly recommending high-risk investments like IHC – Ashbrook DST.
Despite the risks, brokerage firms may continue to recommend DSTs because of the high commissions associated with their sale and creation.
Fortunately, FINRA provides an arbitration forum for investors to resolve disputes if a broker or brokerage firm makes an unsuitable investment recommendation or fails to adequately disclose the associated risks. Brokerage firms could be held liable for investment losses through a FINRA arbitration claim.
The White Law Group – Free Consultation
If you have suffered investment losses in IHC – Ashbrook DST, please call the securities attorneys at The White Law Group at 888-637-5510 for a free consultation.
The White Law Group is a national securities fraud, securities arbitration, and investor protection law firm with offices in Chicago, Illinois and Seattle, Washington.
FAQs
- What are the risks of investing in a DST?
DSTs offer no liquidity, limited control, and cannot raise new capital after the offering—exposing investors to risks such as property damage, market shifts, or decreased rental income. - How do I know if my broker violated FINRA rules?
If your advisor didn’t fully disclose the risks or recommended this DST without considering your financial profile, it may constitute a violation of suitability requirements. - What is the status of IHC – Ashbrook DST?
The sponsor suspended new offerings and distributions in July 2025, is under SEC review, and transferred management to third parties.
